Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sourav Kalra

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Biomolecular Structure & Dynamics|August 21, 2018
Computational investigation of binding mechanism of substituted pyrazinones targeting corticotropin releasing factor-1 receptor deliberated for anti-depressant drug designMishra Shashank Shekhar, T Venkatachalam, Chandra Shekhar Sharma, et al.
Journal of Biomolecular Structure & Dynamics|July 16, 2020
Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studiesShashank Shekhar Mishra, Shashi Ranjan, Chandra Shekhar Sharma, et al.
European Journal of Clinical Pharmacology|June 26, 2018
Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening arraySourav Kalra, Raman Preet Kaur, Abhilash Ludhiadch, et al.
ACS Nano|June 24, 2020
Nanotechnology for COVID-19: Therapeutics and Vaccine ResearchGaurav Chauhan, Marc J Madou, Sourav Kalra, et al.
RSC Medicinal Chemistry|January 22, 2021
Anticancer potential of some imidazole and fused imidazole derivatives: exploring the mechanism <i>via</i> epidermal growth factor receptor (EGFR) inhibitionSourav Kalra, Gaurav Joshi, Manvendra Kumar, et al.
European Journal of Medicinal Chemistry|September 8, 2019
Recent advancements in mechanistic studies and structure activity relationship of F<sub>o</sub>F<sub>1</sub> ATP synthase inhibitor as antimicrobial agentRakesh Narang, Raj Kumar, Sourav Kalra, et al.
Archiv Der Pharmazie|May 9, 2018
Anticancer activity of dihydropyrazolo[1,5-c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase IIGagandeep Kaur, Ravi P Cholia, Gaurav Joshi, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 18, 2021
Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase InhibitorsNishtha Shalmali, Sandhya Bawa, Md Rahmat Ali, et al.
Bioorganic Chemistry|October 8, 2019
Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo[1,5-c]quinazolines as potential EGFR inhibitorsArshad J Ansari, Gaurav Joshi, Umesh Prasad Yadav, et al.
Bioorganic Chemistry|February 2, 2024
Exploration of oxadiazole clubbed benzhydrylpiperazine pharmacophoric features as structural feature for antidepressant activity: In vitro, in vivo and in silico analysisNilay Kumar Nandi, Shibam Das, Diksha Choudhary, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Biomolecular Structure & Dynamics|August 21, 2018
Computational investigation of binding mechanism of substituted pyrazinones targeting corticotropin releasing factor-1 receptor deliberated for anti-depressant drug designMishra Shashank Shekhar, T Venkatachalam, Chandra Shekhar Sharma, et al.
Journal of Biomolecular Structure & Dynamics|July 16, 2020
Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studiesShashank Shekhar Mishra, Shashi Ranjan, Chandra Shekhar Sharma, et al.
European Journal of Clinical Pharmacology|June 26, 2018
Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening arraySourav Kalra, Raman Preet Kaur, Abhilash Ludhiadch, et al.
ACS Nano|June 24, 2020
Nanotechnology for COVID-19: Therapeutics and Vaccine ResearchGaurav Chauhan, Marc J Madou, Sourav Kalra, et al.
RSC Medicinal Chemistry|January 22, 2021
Anticancer potential of some imidazole and fused imidazole derivatives: exploring the mechanism <i>via</i> epidermal growth factor receptor (EGFR) inhibitionSourav Kalra, Gaurav Joshi, Manvendra Kumar, et al.
European Journal of Medicinal Chemistry|September 8, 2019
Recent advancements in mechanistic studies and structure activity relationship of F<sub>o</sub>F<sub>1</sub> ATP synthase inhibitor as antimicrobial agentRakesh Narang, Raj Kumar, Sourav Kalra, et al.
Archiv Der Pharmazie|May 9, 2018
Anticancer activity of dihydropyrazolo[1,5-c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase IIGagandeep Kaur, Ravi P Cholia, Gaurav Joshi, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 18, 2021
Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase InhibitorsNishtha Shalmali, Sandhya Bawa, Md Rahmat Ali, et al.
Bioorganic Chemistry|October 8, 2019
Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo[1,5-c]quinazolines as potential EGFR inhibitorsArshad J Ansari, Gaurav Joshi, Umesh Prasad Yadav, et al.
Bioorganic Chemistry|February 2, 2024
Exploration of oxadiazole clubbed benzhydrylpiperazine pharmacophoric features as structural feature for antidepressant activity: In vitro, in vivo and in silico analysisNilay Kumar Nandi, Shibam Das, Diksha Choudhary, et al.
Pageof 4